Last reviewed · How we verify
Neonatal pneumonia
Approved treatments
- Ramycin
Fusidic acid works by inhibiting the function of the bacterial ribosome, preventing the production of essential proteins. - Garamycin · Merck & Co.
- Penicillin G Potassium In Plastic Container · Pfizer
- Vancocin · ANI Pharmaceuticals
- Claforan · Sterimax
- E-Mycin · Generic (originally Abbott/Lilly)
- Gentamicin · Merck & Co.
- Arikayce Kit · Bristol-Myers Squibb
Amikacin works by binding to bacterial ribosomes, inhibiting protein synthesis and ultimately killing the bacteria. - Benzamycin · Pfizer
- penicillin · Karlstad University
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Neonatal pneumonia patent landscape — cliff calendar, originator estates, attackable patents
- Neonatal pneumonia treatment landscape brief
- Neonatal pneumonia treatment updates RSS
Frequently asked questions about Neonatal pneumonia
What drugs treat Neonatal pneumonia?
Tracked treatments include Ramycin, Garamycin, Penicillin G Potassium In Plastic Container, Vancocin, Claforan, E-Mycin, Gentamicin, Arikayce Kit.
What is the treatment for Neonatal pneumonia?
Standard treatment for Neonatal pneumonia includes Ramycin, Garamycin, Penicillin G Potassium In Plastic Container, Vancocin, Claforan. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Neonatal pneumonia patent cliff · Neonatal pneumonia CI report
- Treatment: Ramycin
- Treatment: Garamycin · Merck & Co.
- Treatment: Penicillin G Potassium In Plastic Container · Pfizer
- Treatment: Vancocin · ANI Pharmaceuticals
- Treatment: Claforan · Sterimax
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing